[ESPR] QoQ Quarter Result on 30-Sep-2001 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
29-Sep-2001
Financial Year
2001
Quarter
30-Sep-2001 [#Q3]
Profit Trend
QoQ- 0.70%
YoY- 41.86%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 31/12/00 CAGR
Revenue 0 0 0 0 1 1 1 -
PBT -7,824 -7,303 -6,344 -6,281 -6,325 -5,981 -6,803 9.79%
Tax 888 314 -112 736 -454 -976 1,233 -19.70%
NP -7,824 -7,303 -6,344 -6,281 -6,325 -5,981 -5,565 25.57%
Tax Rate - - - - - - - -
Total Cost 7,824 7,303 6,344 6,281 6,326 5,982 5,566 25.56%
Ratio Analysis
30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 31/12/00 CAGR
NP Margin 0.00 0.00 0.00 0.00 -632,500.00 -598,100.00 -556,500.00 -
Per Share
30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 31/12/00 CAGR
EPS -1.87 -1.75 -1.57 -1.56 -1.70 -1.61 -2.65 -20.78%
EPS Diluted -1.87 -1.75 -1.57 -1.56 -1.70 -1.61 -2.65 -20.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.